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Three-dimensional matrix primes mesangial cells to down-regulation of
a-smooth muscle actin via deactivation of CArG box elements. Prolonged
culture of mesangial cells forms multifocal nodular structures, termed
“hillocks,” composed of cells and extracellular matrix (ECM), which may
mimic the situation in the glomerular mesangium. Mesangial cells incor-
porated in hillocks show repressed expression of a-smooth muscle actin, a
marker of mesangial cell activation/dedifferentiation. The aim of this
study is to elucidate molecular mechanisms involved in this phenomenon,
focusing on the activity of CArG box elements located in 59-flanking
region of the a-smooth muscle actin gene. Reporter mesangial cells were
created to monitor the activity of CArG elements. These clones expressed
b-galactosidase gene (lacZ) under the control of CArG boxes. Within the
hillocks, reporter cells showed repressed expression of lacZ as well as
a-smooth muscle actin compared to the cells in two-dimensional cultures.
Consistent with this result, the reporter cells embedded in collagen gel
exhibited down-regulation of lacZ and a-smooth muscle actin transcripts.
Deactivation of CArG box elements by transfection with either a domi-
nant negative mutant of serum response factor or a dominant negative
form of ternary complex factor Elk-1 led to depressed expression of
a-smooth muscle actin gene. These data suggested that three-dimensional
ECM primes mesangial cells to down-regulation of a-smooth muscle actin
via deactivation of CArG box elements.
In the renal glomerulus, mesangial cells are surrounded by a
three-dimensional extracellular matrix (ECM), the mesangial
matrix, consisting of basement membrane-type collagens, glyco-
proteins and proteoglycans. Since ECM has profound biological
effects on a variety of cell types, mesangial matrix possibly
regulates the behavior and function of mesangial cells in the
normal glomerular microenvironment. Using gel matrices recon-
stituted in vitro, we previously reported that a three-dimensional
basement membrane gel inhibited migration and proliferation of
cultured mesangial cells [1]. Gene transfection studies showed
that mesangial cells with aberrant matrix-degrading activity exhib-
ited accelerated mitogenesis and migration in vitro [2]. This line of
evidence implied that the mesangial matrix controls the behavior
of mesangial cells to maintain a normal cell phenotype in the
glomerulus.
This hypothesis has been further supported by recent findings
[3]. Prolonged culture of mesangial cells forms nodular structures,
termed “hillocks,” composed of cells and surrounding ECM,
which may mimic the situation in the glomerular mesangium [4].
Incorporation of mesangial cells into this “natural” matrix struc-
ture allowed for transition of the cellular phenotype toward
deactivation and differentiation [3]. Compared to hillock-unasso-
ciated cells, the cells within hillocks showed repressed mitogenic
activity, elevated type IV/I collagen mRNA ratio and suppressed
expression of a-smooth muscle actin, which is similar to the
behavior of normal mesangial cells in vivo [5].
a-Smooth muscle actin is known to be a crucial marker for
activation and dedifferentiation of mesangial cells [5]. In the
normal glomerulus, expression of a-smooth muscle actin is absent
or only faintly detectable, whereas it is markedly up-regulated in
the mesangium during a wide range of experimental and human
glomerular diseases [5–9]. The expression of a-smooth muscle
actin is reversible and correlated with injury of the mesangium
and/or activation of mesangial cells [6, 8–11]. However, currently,
information is limited regarding regulation of the a-smooth
muscle actin expression in pathophysiologic circumstances.
The 59-flanking region of the a-smooth muscle actin gene
contains CC(A/T)6GG sequences (CArG box elements) [12–14],
the binding sites of serum response factor (SRF) and the ternary
complex factor (TCF) subfamily of Ets transcription factors [15].
The CArG box motif, the core consensus sequence of serum
response element (SRE), is crucial for serum-mediated induction
of a-smooth muscle actin in several cell types [12–14]. In rat
mesangial cells, two CArG box motifs in the core promoter
fragment are necessary and sufficient for the serum induction of
a-smooth muscle actin [16]. Based on these data together with our
previous findings, ECMs might affect a-smooth muscle actin
expression via the down-regulation of CArG box elements. Using
the nodular cultures and cultures in gel matrices, the present study
aims at examining this possibility. This report demonstrates that
three-dimensional ECMs transduce a signal that deactivates
CArG box elements and, thereby, attenuate the expression of
a-smooth muscle actin in mesangial cells.
Key words: mesangial cell; a-smooth muscle actin; CArG box element;
serum response element; extracellular matrix.
Received for publication April 30, 1997
and in revised form October 2, 1997
Accepted for publication October 7, 1997
© 1998 by the International Society of Nephrology
Kidney International, Vol. 53 (1998), pp. 690–697
690
METHODS
Mesangial cells and transfectants
Mesangial cells were cultured from isolated glomeruli of a male
Sprague-Dawley rat [17]. Cell clones SM41, SM42 and SM43 were
established by a limiting dilution method and identified as being
of mesangial cell phenotype as described [1]. Cells (passages 10 to
30) were maintained in Dulbecco’s modified Eagle’s medium/
Ham’s F-12 (DME-F12; GIBCO BRL, Gaithersburg, MD, USA)
supplemented with 100 U/ml penicillin G, 100 mg/ml streptomy-
cin, 0.25 mg/ml of amphotericin B and 10 to 20% fetal calf serum
(FCS; GIBCO BRL).
Using a modified calcium phosphate co-precipitation method
[18], SM43 mesangial cells were stably transfected with an expres-
sion plasmid pSRE-lacZ [19]. This construct introduces (i) a
bacterial b-galactosidase gene (lacZ) under the control of three
copies of human c-fos SRE adjacent to a minimal promoter
derived from Rous sarcoma virus, and (ii) a neomycin phospho-
transferase gene (neo) driven by a thymidine kinase promoter.
Stable transfectants were selected in the presence of neomycin
analog G418 (750 mg/ml; Sigma Immunochemicals, St. Louis,
MO, USA), and reporter cells MCAGZ1 and MCAGZ5 were
established. Modifiable expression of the transgene in response to
fetal calf serum (FCS) was confirmed using 5-bromo-4-chloro-3-
indolyl b-D-galactopyranoside (X-gal) assay [20, 21]. MLTRZ mesan-
gial cells that express lacZ under the control of a Moloney murine
leukemia virus long terminal repeat (LTR) [17] were utilized as
control cells. Other control cells of MACTZ that express lacZ
under the control of a b-actin promoter were established by
transfection of SM43 cells with pHbAPr-1-b-gal [22] and pRc/
CMV (Invitrogen, San Diego, CA, USA) that introduces neo.
To investigate the role of CArG box elements in the regulation
of a-smooth muscle actin gene, SM43 cells were stably transfected
with pRc/CMV and pCGNSRFpm1 (a gift from Dr. Ron Prywes
[23]) coding for a mutant serum response factor (SRF), SRFpm1.
Expression of transgenes in the established transfectants,
MmuSRF1 and MmuSRF2, was confirmed by Northern blot
analysis. Mock transfectants were created by transfection with
pRc/CMV alone. SRFpm1 has three point mutations in the basic
region that abolish DNA binding [23]. Since SRF binds to SRE as
a dimer, overexpression of SRFpm1 may act in a transdominant
negative fashion. Indeed, SRFpm1 can heterodimerize with en-
dogenous wild type SRF, form dimers with low DNA binding
activity and thereby attenuate SRE activity in muscle cells (Dr.
Ron Prywes, personal communication).
Transient transfection
Activity of CArG box elements in MmuSRFs was studied by a
transient transfection assay as described before [24]. In brief,
using the calcium phosphate coprecipitation method, cells in
24-well plates (2 3 105/well) were transiently transfected with
pSRE-LacZ (0.5 mg/well). After 48 hours, cells were subjected to
X-gal assay to detect b-galactosidase activity. The activity of
CArG box elements was assessed by counting blue cells stained by
X-gal. To exclude possible variability in transfection efficiency
between different cell clones, the number of X-gal-positive cells in
each was normalized by the number of positive cells transfected
with a control plasmid, pCXL [25] or pCI-bgal (a gift from
Promega, Madison, WI, USA). These expression plasmids intro-
duce lacZ under the control of constitutively active viral regula-
tory elements, that is, the spleen necrosis virus LTR or the
immediate-early enhancer/promoter of human cytomegalovirus,
respectively.
The ternary complex factor Elk-1 is required for activation of
CArG box elements via mitogen-activated protein kinase cascades
[26]. To confirm the crucial role of CArG box elements in the
regulation of a-smooth muscle actin gene, transient transfection
studies were performed using a dominant negative mutant of
Elk-1 [27]. Elk-1 forms complexes with SRF, and binding of
Elk-1-SRF complexes to CArG motifs leads to induction of target
genes. If a dominant-interfering form of Elk-1 is overexpressed,
transacting ability of Elk-1-SRF complexes is abrogated [26]. To
assess activity of the a-smooth muscle actin promoter, an expres-
sion plasmid paAP126 [28] was utilized. This reporter plasmid
introduces lacZ under the control of 2894 to 112 base pairs of
the human a-smooth muscle actin gene. SM43 cells in 24-well
plates were transiently transfected with pSRE-LacZ, paAP126 or
pCI-bgal (0.5 mg/well) together with an empty plasmid or pDN-
Elk (2.5 mg/well) encoding a mutated Elk-1 with deletion of the
carboxy-terminal activation domain [26]. After 48 hours, cells
were subjected to X-gal assay to evaluate the activity of the
a-smooth muscle actin promoter or CArG box elements. The
number of X-gal-positive cells transfected with pSRE-LacZ or
paAP126 was counted and normalized by the number of X-gal-
positive cells transfected with pCI-bgal. All assays were per-
formed in quadruplicate in the presence of 10% FCS.
Activity of Elk-1 was assessed in hillock-associated cells and
unassociated cells using transfection with pGAL4-Elk and
pUASg-LacZ. pGAL4-Elk encodes the Elk-1 activation domain
(residues 307 to 428) fused to the GAL4 DNA-binding domain
[26]. pUASg-LacZ contains lacZ downstream of a promoter
(E1b) linked to five copies of the GAL4-binding site [29].
Superconfluent SM43 cells (4 3 105/well) in 24-well plates were
transiently transfected with pUASg-LacZ (1 mg/well) or a control
plasmid pCIb-gal (1 mg/well), together with pGAL4-Elk (1 mg/
well), under a low serum concentration (0.5% FCS). After
completing the transfection, hillock formation was triggered by
exposure of the cells to 20% FCS. After four days, cells were
subjected to X-gal assay to evaluate the activity of Elk-1. The
number of X-gal-positive cells transfected with pGAL4-Elk and
pUASg-LacZ was counted and normalized by the number of
X-gal-positive cells transfected with pGAL4-Elk and pCI-bgal.
These values were compared between hillock-associated cells and
unassociated cells. Assays were performed in quadruplicate.
X-gal assay
X-gal assay was performed as described before [17]. In brief,
transfectants were fixed in 0.5% glutaraldehyde, 2 mM MgCl2, and
1.25 mM EGTA in phosphate buffered saline (PBS) for 10 minutes
at room temperature, and incubated at 37°C for two to six hours
in X-gal solution containing 1 mg/ml X-gal (Sigma), 20 mM
K3Fe(CN)6, 20 mM K4Fe(CN)6 z 3H2O, 2 mM MgCl2, 0.01%
sodium desoxycholate and 0.02% Nonidet P-40 in phosphate
buffered saline (PBS; pH 7.4).
Development of hillocks
Mesangial cells were cultured in 100 mm plastic plates without
passage for one to two weeks for the development of hillocks [3].
Hillocks were isolated mechanically by a jet of cold PBS until the
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majority of the hillocks were removed from the plates. Isolated
hillocks were washed three times by cold PBS. After the removal
of hillocks, the remaining cells were harvested using a rubber
policeman. Isolated hillocks and hillock-unassociated cells from
identical plates were used for Northern blot analyses. To test
reversibility of altered gene expression, purified hillocks were
trypsinized and re-seeded into six-well culture plates. After sev-
eral days, confluent cells were subjected to Northern analyses.
Stability of mRNAs in hillock-associated cells and unassociated
cells was examined as follows. After the development of hillocks,
cultures were treated with the RNA synthesis inhibitor, actinomy-
cin D (500 ng/ml; Serva, Heidelberg, Germany). Before or after
the treatment for 12 and 24 hours, hillocks and hillock-unassoci-
ated cells were harvested separately and used for Northern
analyses of lacZ and a-smooth muscle actin expression.
Collagen gel culture
MCAGZ5 cells were incorporated in collagen gels as described
previously [1, 30]. In brief, type I collagen solution (1.2 ml)
prepared from tails of rats [30] were mixed on ice with (i) 53
concentrated DME [NaHCO3 (2); GIBCO, 0.4 ml], (ii) recon-
struction buffer (0.14 N NaOH 2 0.26 N NaHCO3; 0.2 ml), and iii)
cell suspension (MCAGZ5; 1 3 106 cells/0.2 ml). The mixture was
poured into wells of six-well culture plates, left for 30 minutes at
37°C to allow for gel formation and fed with 2 ml of DME-F12
containing 20% FCS. After 24 hours of incubation, the collagen
gel was released from the bottom of each well. In this situation,
substantial number of cells populated both on the basement
plastic and within the floating gel. After incubating for an
additional 24 hours in fresh 10% FCS/DME-F12, cells on plastic
and within the gels were harvested separately and subjected to
Northern blot analyses. To examine whether the three-dimen-
sional structure is required for the action of ECM on CArG box
elements, MCAGZ5 cells were seeded on plastic pre-coated with or
without type I collagen, cultured for 48 hours and used for
Northern analyses.
Northern blot analysis
Northern blot analysis was performed as described previously
[31]. Total RNA was extracted by a single-step method, electro-
phoresed on 1.2% agarose gels containing 10% formaldehyde and
transferred onto nitrocellulose membranes. As probes, rat a-vas-
cular smooth muscle actin cDNA [32], b-galactosidase cDNA
[33], SRF cDNA [23] and rat glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) cDNA were labeled with 32P-dCTP using a
random priming method. The membranes were hybridized with
probes at 65°C overnight in a solution containing 4 3 SSC (600
mM sodium chloride, 60 mM sodium citrate), 53 Denhardt’s
solution, 10% dextran sulfate, 50 mg/ml herring sperm DNA and
50 mg/ml poly(A). The hybridized membranes were washed four
times in 4 3 SSC/0.1% SDS at 50°C and exposed to Kodak XAR
films with intensifying screens at 280°C. Densitometric analyses
were performed using a computerized program, NIH Image.
Statistical analysis
Data were expressed as means 6 SE. Statistical analysis was
performed using the non-parametric Mann-Whitney test to com-
pare data in different groups. P value of ,0.05 was used to
indicate a statistically significant difference.
RESULTS
Expression of a-smooth muscle actin in hillock-associated cells
and unassociated cells
Mesangial cell clones, SM41, SM42 and SM43 were established
from isolated glomeruli of a Sprague-Dawley rat and used for
development of hillocks. Hillocks and hillock-unassociated cells
were isolated from each culture and subjected to Northern blot
analysis of a-smooth muscle actin expression. In all clones,
expression of the transcript (1.5 kb) was significantly repressed in
hillock-associated cells compared to unassociated cells (46.5 6
4.0% versus unassociated cells; 100%, mean 6 SE; Fig. 1). This is
consistent with our early report using uncloned mesangial cells
derived from a different rat strain [3].
Correlation between CArG box activity and a-smooth muscle
actin expression
The CArG box motif is known to be the important regulatory
element located in the 59-flanking region of the a-smooth muscle
actin gene [16]. Using the established reporter clones MCAGZ1
and MCAGZ5, correlation between CArG box activity and
a-smooth muscle actin expression was investigated in nodular
cultures (Fig. 2A). Northern blot analysis revealed that, in the
presence of 10% FCS, CArG box elements were constitutively
active in hillock-unassociated cells. This was correlated with their
substantial expression of the a-smooth muscle actin gene. In both
reporter clones, expression of lacZ was repressed in hillock-
associated cells compared to unassociated cells. This was closely
correlated with downregulation of the a-smooth muscle actin
mRNA in hillock-associated cells. In control clones MLTRZ and
MACTZ that express lacZ under the control of viral LTR or a
b-actin promoter, expression of a-smooth muscle actin was simi-
larly repressed in hillock-associated cells, but the expression of
lacZ was unaltered.
To investigate reversibility of the suppressed activity of CArG
elements in hillock-associated cells, hillocks were trypsinized,
dispersed and re-seeded on a plastic substratum. Within several
days, the dissociated hillocks regained higher levels of CArG box
Fig. 1. Expression of a-smooth muscle actin mRNA in hillock-associated
mesangial cells and unassociated cells. Hillock-unassociated cells (U) and
associated cells (A) were harvested from an identical culture of rat
mesangial cell clones SM41, SM42 and SM43. Northern blot analysis was
performed on a-smooth muscle actin (a-SMA) expression. Expression of
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and staining of
28S and 18S ribosomal RNAs with ethidium bromide are shown as loading
controls.
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activity and a-smooth muscle actin expression, both of which are
typical of hillock-unassociated cells (Fig. 2B).
Stability of mRNAs in hillock-associated cells and unassociated
cells was examined using an inhibitor of RNA synthesis. After the
development of hillocks, cultures were treated with actinomycin
D. Before and after the treatment for 12 and 24 hours, hillocks
and hillock-unassociated cells were harvested separately from
identical plates, and degradation rates of mRNAs were examined
by Northern blot analyses. As demonstrated in Figure 2C, stability
of lacZ and a-smooth muscle actin transcripts in hillock-associ-
ated cells was identical to that in hillock-unassociated cells.
Activity of Elk-1 in hillock-associated cells and unassociated
cells
The activity of CArG box motif is regulated by ternary complex
factors that form complexes with SRF [15]. To further investigate
mechanism involved in the suppression of CArG box elements in
hillocks, activity of Elk-1, a member of the TCF family, was
compared between hillock-associated cells and unassociated cells.
Confluent mesangial cells were transiently transfected with
pUASg-LacZ or a control plasmid pCIb-gal, together with
pGAL4-Elk. After completing the transfection, hillocks were
induced by exposure of the cells to 20% FCS. X-gal assay revealed
that hillock-unassociated cells exhibited substantial activity of
Elk-1. This constitutive activity was significantly suppressed in the
cells incorporated in hillocks (Fig. 3).
Depression of a-smooth muscle actin in mesangial cells by
deactivation of CArG box elements
To examine whether inactivation of CArG elements leads to
suppressed expression of a-smooth muscle actin gene, mesangial
cells were stably transfected with a gene encoding a transdomi-
nant negative mutant of SRF, the essential component for CArG
box activation [34]. Northern blot analysis revealed that mesangial
cells constitutively expressed the endogenous SRF transcript.
Established transfectants MmuSRF1 and MmuSRF2 exhibited an
additional transgene transcript (Fig. 4A). Transient transfection
assays revealed that, compared to mock transfected cells,
MmuSRF cells showed attenuated activity of CArG box elements
[60.0 6 2.9% versus control (100%); Fig. 4B]. Using these clones,
expression of a-smooth muscle actin gene was investigated in
two-dimensional cultures. As shown in Figure 4C, the expression
of a-smooth muscle actin was downregulated in both MmuSRF1
cells (31%) and MmuSRF2 cells (49%) compared to controls
(100%).
To further confirm that the inactivation of CArG box elements
Fig. 2. Activity of CArG box elements in hillock-
associated cells and unassociated cells. SM43
mesangial cells were stably transfected with
pSRE-LacZ that introduces a bacterial b-galac-
tosidase gene (lacZ) under the control of three
copies of c-fos CArG box elements, and reporter
cells MCAGZ1 and MCAGZ5 were established. As
control clones, MLTRZ and MACTZ mesangial
cells were used. MLTRZ cells express lacZ under
the control of a Moloney murine leukemia virus
long terminal repeat, and MACTZ cells express
lacZ under the control of a b-actin promoter. (A)
Correlation between CArG box activity and
a-smooth muscle actin expression. Hillock-unas-
sociated cells (U) and associated cells (A) were
harvested from an identical culture of the re-
porter clone MCAGZ1, MCAGZ5, MLTRZ or
MACTZ. Northern blot analyses were performed
on lacZ and a-smooth muscle actin expression.
(B) Reversibility of CArG box activity. Purified
hillocks composed of MCAGZ5 cells were
trypsinized and re-seeded on plastic (A-.U).
After several days, expression of lacZ as well as
a-smooth muscle actin was compared to that in
hillock-associated cells before trypsinization (A).
(C) Stability of mRNAs. After the development
of hillocks, cultures were treated with the inhib-
itor of RNA synthesis, actinomycin D (500 ng/
ml). Before or after the treatment for 12 and 24
hours, hillock-associated cells (F) and unassoci-
ated cells (E) were harvested separately from
identical culture plates and used for Northern
analyses of lacZ and a-smooth muscle actin ex-
pression.
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in hillocks was causative of the suppressed a-smooth muscle actin
expression, transfection studies were conducted. Mesangial cells
were transiently transfected with pSRE-LacZ, paAP126 or pCI-
bgal, together with an empty plasmid or pDN-Elk, and activities
of the a-smooth muscle actin promoter and CArG box elements
were assessed by X-gal assay. As previously reported [26, 27],
introduction of the dominant negative form of Elk-1 markedly
repressed the basal activity of CArG box elements [5.9 6 5.9%
versus control (100%); Fig. 4D, left]. Consistent with the results
from MmuSRF cells, inactivation of CArG box elements by the
Elk-1 mutant also substantially repressed activity of the a-smooth
muscle actin promoter [11.7 6 2.3% versus control (100%); Fig.
4D, right].
Activity of CArG box elements and expression of a-smooth
muscle actin in mesangial cells embedded in collagen gels
To investigate the potential of three-dimensional ECMs for
modulating the activity of CArG elements, MCAGZ5 cells were
embedded in collagen gels, and expression of lacZ and a-smooth
muscle actin was compared to that of the cells on plastic (Fig. 5A).
Consistent with the results from hillocks, the three-dimensional
gel matrix dramatically inhibited the expression of lacZ as well as
a-smooth muscle actin gene. Thin coating of plastic with type I
collagen failed to induce down-regulation of lacZ and a-smooth
muscle actin in the reporter mesangial cells (Fig. 5B).
DISCUSSION
Expression of a-smooth muscle actin alters in certain cell types
in response to local pathophysiologic conditions. For example,
normally, fibroblasts in various organs do not express a-smooth
muscle actin, whereas after insults, activated fibroblasts (myofi-
broblasts) abundantly synthesize this actin isoform [35]. Similarly,
in glomerular mesangial cells, a-smooth muscle actin is expressed
exclusively under pathologic situations and has been regarded as
a crucial marker for cytoactivation and dedifferentiation [5].
Various peptide factors may function as potential regulators of
a-smooth muscle actin expression. Those include; angiotensin II,
endothelin-1, arginin vasopressin, transforming growth factor-b,
platelet-derived growth factor (PDGF), granulocyte macrophage-
colony stimulating factor and interferon-g [36–41]. However,
currently, information is limited regarding other environmental
factors that regulate the expression of a-smooth muscle actin.
Using nodular culture and collagen gel culture methods, this study
addresses a novel potential of three-dimensional ECMs for down-
regulation of a-smooth muscle actin expression in mesangial cells.
The three-dimensional structure was found to be essential for this
action, since a collagen-coated plastic failed to exert this biologic
activity.
In rat mesangial cells, a core fragment of the a-smooth muscle
actin promoter from positions 2122 to 11 is crucial for serum
induction of the a-smooth muscle gene [16]. This sequence
contains two highly conserved CArG box motifs that alone confer
maximum levels of serum inducibility on a heterologous minimal
promoter. Deletion of either sequence reduces the target gene
transcription, suggesting that both CArG box elements are re-
quired for efficient transcription [16]. This has led us to examine
the activity of CArG box elements in mesangial cells incorporated
in hillocks and collagen gels. In this study, reporter mesangial cells
in ECMs exhibited repressed activity of CArG box elements
compared to the cells in two-dimensional cultures. In both
experimental settings, matrix-associated and unassociated cells
were located in the identical culture media containing 10 to 20%
FCS that stimulates CArG box elements in MCAGZ cells [21].
These data imply that three-dimensional ECMs may blunt the
sensitivity of the cells to serum factor(s).
Extracellular matrix is known to generate intracellular signal-
ling via the cell surface receptors, integrins, and modulate tran-
scription of various genes [42]. Marx and coworkers reported that
three-dimensional cultures using a collagen gel resulted in a
remarkable down-regulation of PDGF-b-receptors on the surface
of mesangial cells [43]. Since PDGF is a stimulator of CArG
elements in mesangial cells [44] and is present in the basal growth
media containing serum, the unresponsiveness to PDGF via
down-regulation of its receptor may explain the attenuated CArG
box activity.
Another possible mechanism is via focal adhesion kinase
(FAK). FAK is a nonreceptor protein-tyrosine kinase implicated
in controlling cellular responses to the engagement of cell surface
receptor integrins [45]. Following ligation with ECM components,
integrins initiate phosphorylation of FAK and consequently mod-
ulate cell behavior including spreading, migration, proliferation
and gene expression [46]. Based on this action, the surrounding
ECM may continuously activate FAK and affect the activity of
CArG elements in hillock-associated cells. Interestingly, we re-
cently found that v-Src, an well-known activator of FAK, re-
pressed both activity of CArG box elements and expression of
a-smooth muscle actin in mesangial cells [47]. Three-dimensional
ECMs might suppress CArG box activity via integrin-mediated
activation of FAK.
To examine whether functional inactivation of CArG elements
leads to repressed a-smooth muscle actin expression, mesangial
cells were transfected with a cDNA encoding a transdominant
negative mutant of SRF, an essential component for CArG box
activation. The established transfectants showed reduced activity
of CArG box elements and repressed expression of a-smooth
Fig. 3. Activity of Elk-1 in hillock-associated cells and unassociated cells.
Superconfluent SM43 cells were transiently transfected with pUASg-LacZ
or a control plasmid pCIb-gal, together with pGAL4-Elk. After complet-
ing the transfection, hillocks were induced by exposure of the cells to 20%
FCS. Activity of Elk-1 was evaluated by 5-bromo-4-chloro-3-indolyl b-D-
galactopyranoside (X-gal) assay. The number of X-gal-positive cells
transfected with pGAL4-Elk and pUASg-LacZ was counted and normal-
ized by the number of X-gal-positive cells transfected with pGAL4-Elk
and pCI-bgal. The value (mean 6 SE) of hillock-associated cells (A) was
expressed as a relative percentage against the value of hillock-unassoci-
ated cells (U: 100%). Assays were performed in quadruplicate. An asterisk
indicates statistically significant difference (P , 0.05).
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muscle actin gene. Furthermore, transient transfection with the
dominant negative mutant of Elk-1, another crucial component
for CArG box activation, markedly suppressed the activity of
a-smooth muscle actin promoter, confirming that inactivation of
CArG elements was causative of the depressed a-smooth muscle
actin in mesangial cells surrounded by ECMs.
Currently, correlation between the activity of CArG box ele-
ments and other phenotypic markers such as mitogenic activity is
unknown. However, it is worthwhile to note that, in mesangial
cells (i) PDGF is a prominent mitogenic factor in vivo and in vitro
[48], (ii) PDGF induces egr-1 expression via activation of CArG
box elements [44], and (iii) inhibition of egr-1 by antisense
oligonucleotides suppresses PDGF-induced mitogenesis [49].
Inactivation of CArG elements possibly affects other phenotypic
properties of mesangial cells towards deactivation and differenti-
ation.
In this study, the role of three-dimensional ECMs was brought
into focus to explain the phenotypical shift of mesangial cells in
hillocks. However, the expression of a-smooth muscle actin and
the activity of CArG box elements might be controlled via other
mechanisms. Following the three-dimensional organization of
cells, several environmental differences may be created, such as
alterations in cell-cell contact, cell-matrix interaction and diffu-
sion rates of oxygen, nutrients, growth factors and metabolic
products. These differences in microenvironment may affect cell
functions and could be, in part, responsible for the phenotypic
change of mesangial cells in hillocks.
In summary, the present data suggested the potential impor-
tance of mesangial matrix as a modifier of mesangial cell pheno-
type. The CArG box element was found to be a molecular target
involved in this regulatory process. To our knowledge, this study
provides the first evidence that the CArG box activity is control-
lable by signals initiated by three-dimensional ECMs.
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Fig. 4. Effect of inactivation of CArG box elements on transcrip-
tional activity of the a-smooth muscle actin gene. (A) Creation of
stable transfectants that express a transdominant negative mutant
of serum response factor (SRF). SM43 cells were transfected with
pCGNSRFpm1 encoding a dominant negative form of SRF, and
stable transfectants MmuSRF1 and MmuSRF2 were established.
Expression of endogenous SRF and exogenous mutant SRF
(muSRF) in untransfected cells, mock transfected cells and
MmuSRF cells was examined by Northern analysis. (B) Activity of
CArG box elements in MmuSRF cells. Mock transfected cells and
MmuSRF1 cells were transiently transfected with pSRE-LacZ.
After 48 hours, cells were subjected X-gal assay to evaluate
b-galactosidase activity. The activity of CArG box elements was
assessed by counting blue cells stained by X-gal. To exclude
possible variability in transfection efficiency between different cell
clones, the number of X-gal-positive cells was normalized by the
number of positive cells transfected with a control plasmid pCXL.
Data were expressed as means 6 SE. Assays were performed in
quadruplicate. An asterisk indicates statistically significant differ-
ence (P , 0.05). (C) Expression of a-smooth muscle actin mRNA in MmuSRF cells. Untransfected cells, mock transfected cells and MmuSRF cells
in monolayer culture were subjected to Northern blot analysis. (D) Inactivation of CArG box elements by a transdominant negative mutant of Elk-1
and altered activity of the a-smooth muscle actin promoter. SM43 cells were transiently transfected with pSRE-LacZ, paAP126 or a control plasmid
pCI-bgal, together with an empty plasmid or pDN-Elk. paAP126 introduces lacZ under the control of 2894 to 112 base pairs of the human a-smooth
muscle actin gene. pDN-Elk encodes a mutant Elk-1 that has deletion of the carboxy-terminal activation domain. After 48 hours, cells were subjected
to X-gal assay to evaluate the activities of CArG box elements and the a-smooth muscle actin promoter. The number of X-gal-positive cells transfected
with pSRE-LacZ or paAP126 was counted and normalized by the number of X-gal-positive cells transfected with pCI-bgal. Data are presented as
relative percentages against controls [pSRE-LacZ or paAP126 1 empty vector (100%)]. Assays were performed in quadruplicate. Asterisks indicate
statistically significant differences (P , 0.05).
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APPENDIX
Abbreviations used in this article are: CArG box, CC(A/T)6GG se-
quences; DME-F-12, Dulbecco’s modified Eagle’s medium/Ham’s F-12;
ECM, extracellular matrix; FAK, focal adhesion kinase; FCS, fetal calf
serum; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; lacZ, b-ga-
lactosidase gene; LTR, long terminal repeat; neo, neomycin phosphotrans-
ferase gene; PBS, phosphate buffered saline; PDGF, platelet-derived
growth factor; SRE, serum response element; SRF, serum response factor;
TCF, ternary complex factor; X-gal, 5-bromo-4-chloro-3-indoyl b-D-galac-
topyranoside.
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